Author | Susan Galbraith, MD, PhD | OncLive

Author | Susan Galbraith, MD, PhD

Articles

Dr. Galbraith Discusses Phase I/II Results for AZD9291 in Advanced NSCLC

September 29, 2014

Video

Susan Galbraith, MD, PhD, head, Oncology Innovative Medicine, AstraZeneca, discusses updated data from the ongoing phase I/II AURA study looking at AZD9291 for NSCLC.

Dr. Galbraith Discusses the Development of AZD9291

July 01, 2014

Video

Susan Galbraith, MD, PhD, head, Oncology Innovative Medicine, AstraZeneca, discusses the development of AZD9291 for lung cancer.

x